SAVAL Trademark

Trademark Overview

On Wednesday, December 15, 2021, a trademark application was filed for SAVAL with the United States Patent and Trademark Office. The USPTO has given the SAVAL trademark a serial number of 97174081. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Saturday, April 6, 2024. This trademark is owned by Boston Scientific Scimed, Inc.. The SAVAL trademark is filed in the Medical Instrument Products category with the following description:

Medical devices for use in peripheral vascular procedures, namely, drug eluting stents and stent delivery systems
saval

General Information

Serial Number97174081
Word MarkSAVAL
Filing DateWednesday, December 15, 2021
Status730 - FIRST EXTENSION - GRANTED
Status DateSaturday, April 6, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 22, 2023

Trademark Statements

Goods and ServicesMedical devices for use in peripheral vascular procedures, namely, drug eluting stents and stent delivery systems

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateMonday, December 20, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoston Scientific Scimed, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressMaple Grove, MN 55311
Party NameBoston Scientific Scimed, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressMaple Grove, MN 55311

Trademark Events

Event DateEvent Description
Saturday, December 18, 2021NEW APPLICATION ENTERED
Monday, December 20, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 12, 2022ASSIGNED TO EXAMINER
Saturday, September 24, 2022NON-FINAL ACTION WRITTEN
Saturday, September 24, 2022NON-FINAL ACTION E-MAILED
Friday, February 24, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, September 24, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 24, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, February 24, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 24, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 24, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, March 16, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, March 16, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, March 16, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 16, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, March 16, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 4, 2023ASSIGNED TO EXAMINER
Tuesday, July 18, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 22, 2023PUBLISHED FOR OPPOSITION
Wednesday, August 2, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 22, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, April 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 17, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, April 4, 2024SOU EXTENSION 1 FILED
Thursday, April 4, 2024SOU EXTENSION 1 GRANTED
Tuesday, September 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 3, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, September 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 3, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, April 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

saval stents eluting stent delivery systems drug namely devices peripheral vascular